Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
Kirsi M. Kinnunen, Adam J. Schwarz, Emily C. Turner, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J. Tabrizi, Carlos Estevez‐Fraga, Willeke M. C. van Roon‐Mom, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 7, pp. 645-658
Open Access | Times Cited: 203
A biological classification of Huntington's disease: the Integrated Staging System
Sarah J. Tabrizi, Scott Schobel, Emily C. Gantman, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 7, pp. 632-644
Open Access | Times Cited: 171
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
Andrew Jiang, Renée R. Handley, Klaus Lehnert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13021-13021
Open Access | Times Cited: 53
Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes
LingXiao Cao, Jin‐Hui Yin, Gang Du, et al.
Brain and Behavior (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 7
Exploring Huntington’s Disease Diagnosis via Artificial Intelligence Models: A Comprehensive Review
Sowmiyalakshmi Ganesh, Thillai Chithambaram, Nadesh Ramu Krishnan, et al.
Diagnostics (2023) Vol. 13, Iss. 23, pp. 3592-3592
Open Access | Times Cited: 13
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
Sarah Aqel, Jamil Ahmad, Iman Saleh, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 129-129
Open Access
Polyamines signalling pathway: A key player in unveiling the molecular mechanisms underlying Huntington’s disease
Amit Shiwal, Dhanshree Nibrad, Manasi Tadas, et al.
Neuroscience (2025)
Closed Access
Multiple Copper Ions Bind to and Promote the Oligomerization of Huntingtin Protein with Nonpathological Repeat Expansions
Deepa Neupane, Miguel Santos-Fernandez, Francisco Fernandez‐Lima, et al.
Biochemistry (2025)
Closed Access
Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease
Aline Delva, Koen Van Laere, Wim Vandenberghe
Movement Disorders (2023) Vol. 38, Iss. 8, pp. 1515-1526
Open Access | Times Cited: 12
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
Diane Stephenson, Ramona Belfiore‐Oshan, Yashmin Karten, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1682-1691
Open Access | Times Cited: 12
Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
Mária Judit Molnár, Viktor Molnár, Mariann Fedor, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 17
Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group
Nicola Z. Hobbs, Marina Papoutsi, Aline Delva, et al.
Journal of Huntington s Disease (2024) Vol. 13, Iss. 2, pp. 163-199
Open Access | Times Cited: 3
Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI
Jingwen Yao, Melanie A. Morrison, Angela Jakary, et al.
Journal of Magnetic Resonance Imaging (2024) Vol. 60, Iss. 4, pp. 1484-1499
Open Access | Times Cited: 2
Elucidating the Impact of Deleterious Mutations on IGHG1 and Their Association with Huntington’s Disease
Alaa Shafie, Amal Adnan Ashour, Farah Anjum, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 380-380
Open Access | Times Cited: 2
Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
Iñigo Ruiz‐Barrio, Anna Vázquez‐Oliver, Arnau Puig‐Davi, et al.
Movement Disorders (2024) Vol. 39, Iss. 11, pp. 2067-2074
Closed Access | Times Cited: 2
A natural history study to track brain and spinal cord changes in individuals with Friedreich’s ataxia: TRACK-FA study protocol
Nellie Georgiou‐Karistianis, Louise A. Corben, Kathrin Reetz, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0269649-e0269649
Open Access | Times Cited: 10
In vivo CRISPR base editing for treatment of Huntington′s disease
Shraddha Shirguppe, Michael Gapinske, Devyani Swami, et al.
(2024)
Closed Access | Times Cited: 1
Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial
Mohsen Ghofrani-Jahromi, Govinda Poudel, Adeel Razi, et al.
NeuroImage Clinical (2024) Vol. 43, pp. 103650-103650
Open Access | Times Cited: 1
Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington’s Disease: A Review of Data from Mouse Models
Jenna Hanrahan, Drew P. Locke, Lindsay S. Cahill
Journal of Huntington s Disease (2024) Vol. 13, Iss. 3, pp. 279-299
Open Access | Times Cited: 1
Neuroimaging biomarkers in Huntington's disease: Preparing for a new era of therapeutic development
Thilo van Eimeren, Kathrin Giehl, Kathrin Reetz, et al.
Parkinsonism & Related Disorders (2023) Vol. 114, pp. 105488-105488
Closed Access | Times Cited: 3
Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials
Kirsi M. Kinnunen, Ariana P. Mullin, Dorian Pustina, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 7
Predicting Huntington’s disease state with ensemble learning & sMRI: more than just the striatum
Maitrei Kohli, Dorian Pustina, John Harley Warner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Huntington’s Disease Regulatory Science Consortium: Accelerating Medical Product Development
Emily C. Turner, Emily C. Gantman, Cristina Sampaio, et al.
Journal of Huntington s Disease (2022) Vol. 11, Iss. 2, pp. 97-104
Closed Access | Times Cited: 3
Revolutionizing clinical research and communication in Huntington's disease: The Huntington's disease integrated staging system (HD-ISS)
Cristina Sampaio, Jeffrey D. Long, Alexandra Mansbach, et al.
Elsevier eBooks (2024), pp. 41-56
Closed Access
A 12-year polysomnographic study in Huntingtons: sleep problems predict disease onset and severity
Zanna Voysey, Anna Goodman, Lorraine Rogers, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top